Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-15 | 365.5 | 58 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | IL-15 | 343.0 | 73 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-15 | 302.0 | 55 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-15 | 353.5 | 58 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 380.0 | 73 | ||||
RA1869 | 3 | IL-15 | 353.5 | 68 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 360.0 | 73 | ||||
N2759 | 3 | IL-15 | 343.0 | 69 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 346.0 | 72 | ||||
RA1931 | 3 | IL-15 | 410.0 | 55 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 341.0 | 67 | ||||
N2586 | 3 | IL-15 | 295.0 | 50 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 353.0 | 55 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 344.0 | 87 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 327.5 | 52 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 362.0 | 73 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 352.0 | 57 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 363.0 | 69 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 319.5 | 54 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 315.0 | 61 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 655.0 | 65 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 1070.0 | 67 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 758.0 | 50 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 735.5 | 60 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-15 | 698.0 | 62 |